CONDITIONS • WESTMINSTER, ARVADA, BROOMFIELD, THORTON & DENVER METRO

PMDD Treatment in Westminster, CO

Premenstrual dysphoric disorder is not an exaggerated version of PMS and it is not a psychological weakness. It is a distinct neurological and hormonal condition with specific, identifiable biological mechanisms that respond to targeted treatment.

PMDD affects up to 8 percent of women in their reproductive years and is one of the most significantly underdiagnosed and undertreated conditions in women's medicine. The predictable monthly deterioration in mood, cognition, pain tolerance, and overall functioning is not inevitable. It has specific causes — and those causes can be addressed directly, with or without pharmaceutical intervention.

Schedule Online

(970) 716-0557

Same-Day & Same-Week Appointments Available

WE UNDERSTAND WHAT YOU'RE GOING THROUGH

Every month, reliably, a version of yourself arrives that you do not recognize and cannot control — and then disappears again the moment your period starts, as though none of it happened.

If you have PMDD, you know the calendar better than anyone. You know which week of the month is coming by the way you feel before you have even checked a date. The rage that arrives without proportionate cause. The despair that convinces you, with complete certainty, that your life is falling apart — and then lifts two days later like a weather system moving through. The physical symptoms: the bloating and breast pain so severe you cannot wear your normal clothes, the headaches, the joint aches, the exhaustion so heavy that getting out of bed requires effort that is hard to describe to someone who has not felt it. The way your relationships suffer, your work suffers, your sense of yourself suffers, for one to two weeks out of every four. You may have been told this is just bad PMS. You may have been offered an antidepressant. You may have been dismissed, or had your own experience of the severity minimized, in a way that added shame to what is already a profoundly difficult condition to live with. PMDD is a real, documented neurobiological condition. It has specific drivers. And it deserves specific, comprehensive treatment.

YOU MAY BE EXPERIENCING

Severe mood changes in the 1 to 2 weeks before menstruation: depression, anxiety, irritability, or rage disproportionate to circumstances
A subjective sense that everything is hopeless or overwhelming that resolves predictably with the onset of menstruation
Difficulty concentrating, brain fog, and feeling mentally slowed during the luteal phase
Severe bloating, breast tenderness, and physical discomfort in the days before menstruation
Joint pain, headaches, and heightened pain sensitivity during the premenstrual phase
Profound fatigue and sleep disruption that does not match the rest of the month
Relationship strain, work impairment, or social withdrawal that follows a clear and predictable monthly pattern

THE CONNECTION TO PAIN

PMDD dramatically amplifies pain sensitivity. During the luteal phase, the neurological changes of PMDD lower pain thresholds throughout the body — meaning existing musculoskeletal conditions, headaches, and joint problems all become significantly worse in the premenstrual window. This is not coincidental. The same neurobiological shifts driving the mood symptoms are simultaneously reducing the nervous system's ability to regulate pain.

If you have chronic pain that reliably worsens before your period, PMDD-related central sensitization is almost certainly a significant contributing factor — one that cannot be addressed by structural treatment alone.

WHAT YOU PROBABLY HAVEN'T BEEN TOLD

PMDD is not caused by abnormal hormone levels. It is caused by an abnormal brain response to normal hormonal fluctuations — and that distinction changes everything about how it should be treated.

WHAT IS ACTUALLY HAPPENING IN PMDD — AND WHY HORMONE TESTING SO OFTEN COMES BACK NORMAL

Most women with PMDD have been told, after a hormone panel, that their estrogen and progesterone levels are normal. This is both true and completely beside the point. PMDD is not a condition of abnormal hormones. It is a condition in which the brain and nervous system are abnormally sensitive to the normal hormonal fluctuations of the luteal phase of the menstrual cycle. As estrogen drops and progesterone rises after ovulation, a cascade of neurological changes follows. In most women, these changes are mild and manageable. In women with PMDD, the same hormonal shift produces profound changes in the brain's serotonin system, GABA receptor function, and the HPA stress axis — producing the emotional dysregulation, cognitive changes, and heightened reactivity that characterize the condition.

Progesterone's primary metabolite — a compound called allopregnanolone — normally acts as a calming agent in the brain by enhancing the activity of GABA receptors, which are the brain's primary inhibitory system. In women with PMDD, the brain's GABA receptors appear to respond paradoxically to allopregnanolone, producing anxiety and dysphoria rather than calm. This is a neurological sensitivity pattern, not a hormonal deficiency — and it explains why simply adding or removing hormones rarely fully resolves the condition. What it does respond to is a combination of approaches that reduce the underlying neurological sensitivity, support the neurotransmitter systems whose function is disrupted during the luteal phase, and address the nutritional and systemic factors that amplify the severity of the neurological response.

The serotonin connection — and why SSRIs only partially address it

Serotonin plays a central role in PMDD. Luteal phase estrogen withdrawal reduces serotonin availability in the brain, and women with PMDD are more sensitive to this reduction than women without the condition. SSRIs (selective serotonin reuptake inhibitors) address this directly and are genuinely effective for many PMDD patients, either taken continuously or only during the luteal phase. What they do not address are the nutritional precursors to serotonin synthesis — most importantly tryptophan, B6, magnesium, and zinc — all of which are required for the body to produce adequate serotonin in the first place. Women with nutritional deficiencies in these co-factors can have an impaired serotonin production capacity that a reuptake inhibitor cannot compensate for, no matter how efficiently it recycles the serotonin that is available.

Vitamin B6 specifically is required for the conversion of tryptophan into serotonin. Deficiency — which is common — directly impairs serotonin production and worsens PMDD severity independently of any other factor.

Magnesium — the most important nutritional intervention in pmdd

Magnesium is consistently found to be lower in women with PMDD than in those without it, and multiple clinical trials have demonstrated that magnesium supplementation significantly reduces the mood symptoms, fluid retention, bloating, and pain of PMDD. Magnesium is required for GABA receptor function, serotonin synthesis, and the regulation of the HPA stress axis. Its deficiency directly worsens every aspect of the neurological sensitivity that drives PMDD. Magnesium levels drop further during the luteal phase as physiological demands on the system increase — which is one reason symptoms worsen specifically in that window. Correcting magnesium deficiency does not merely reduce premenstrual symptoms. It addresses one of the primary biochemical mechanisms driving the condition, and it does so without side effects and with effects that improve across multiple body systems simultaneously.

Magnesium is one of the few nutrients with direct clinical trial evidence specifically in PMDD — yet it is almost universally absent from standard PMDD management conversations.

The HPA axis, cortisol, and why stress makes PMDD dramatically worse

The HPA axis — the hormonal stress response system — is hyperreactive in PMDD. During the luteal phase, when PMDD symptoms are active, the system is already in a state of heightened sensitivity. Any additional stressor — work pressure, poor sleep, dietary disruption, or a demanding physical event — produces a disproportionately large cortisol response that further amplifies the mood dysregulation, pain sensitization, and emotional reactivity of the condition. This is why PMDD is reliably worse during stressful periods in life and why lifestyle factors have such a large impact on symptom severity. It also explains why autonomic regulation — bringing the HPA axis out of chronic high-alert mode — is one of the most powerful non-pharmacological interventions available. Constitutional hydrotherapy and chiropractic care both directly reduce sympathetic nervous system dominance and lower the baseline HPA reactivity that makes the luteal phase so difficult.

Sleep deprivation is one of the most powerful amplifiers of PMDD severity. Supporting sleep quality through the luteal phase is a primary clinical priority, not a lifestyle afterthought.

OUR APPROACH

Conventional care versus our approach

We work collaboratively with the patient's gynecologist and mental health providers. SSRIs and hormonal management have a genuine role in PMDD care and we fully support their use when appropriate. Our naturopathic approach provides the nutritional, neurological, and systemic assessment that standard PMDD care consistently omits — identifying and addressing the specific biological amplifiers that determine how severe any individual woman's PMDD will be.

The conventional approach

What most patients experience

Diagnosis made clinically through symptom tracking across at least two menstrual cycles confirming the luteal pattern
SSRI prescribed, either continuously or in the luteal phase only
Oral contraceptive pill offered for hormonal suppression, particularly combined pill or continuous cycling
General advice to exercise, reduce caffeine and alcohol, and improve sleep
Nutritional contributors, HPA axis reactivity, gut health, thyroid function, and systemic inflammation never assessed as part of the PMDD picture
Pain amplification during the luteal phase and the musculoskeletal consequences of monthly neurological sensitization not addressed

Standard PMDD care manages the most severe symptoms through serotonergic or hormonal intervention. Its limitation is that it does not investigate or treat the nutritional, metabolic, and autonomic factors that determine the severity of the underlying neurological sensitivity.

Our naturopathic approach

What we do differently

Comprehensive nutritional assessment: magnesium, B6, zinc, iron, vitamin D, and omega-3 status — the specific nutrients required for serotonin synthesis, GABA function, and neurological regulation that are commonly deficient in PMDD
Targeted supplementation matched to identified deficiencies: therapeutic magnesium glycinate, B6 with co-factors, calcium for physical symptoms, and evening primrose oil for prostaglandin balance — each with specific clinical evidence in PMDD
HPA axis and autonomic regulation through constitutional hydrotherapy and chiropractic care — directly reducing the baseline sympathetic hyperreactivity that makes the luteal phase neurologically so destabilizing
Gut health assessment and restoration — the gut produces the majority of the body's serotonin, and dysbiosis directly reduces serotonin availability and increases systemic inflammation that amplifies neurological sensitivity
Thyroid and blood sugar assessment — both hypothyroidism and blood sugar instability independently worsen mood dysregulation and neurological sensitivity, and their presence significantly amplifies PMDD severity in women who have both conditions simultaneously
Pain management integration: for patients with musculoskeletal conditions that worsen premenstrually, addressing the PMDD-driven central sensitization as part of the pain treatment — reducing the monthly window of heightened pain amplification that structural treatment cannot reach

We do not prescribe psychiatric medication or replace mental health care. We provide the biological assessment and treatment that identifies and addresses the specific physiological amplifiers of PMDD severity that standard care does not investigate.

WHAT MAKES OUR APPROACH DIFFERENT — IN A SINGLE PARAGRAPH

Standard PMDD care manages the neurological dysregulation with serotonergic medication or hormonal suppression. Our approach investigates and addresses the specific nutritional, metabolic, and systemic factors that determine how severe that dysregulation will be — the magnesium and B6 deficiencies impairing serotonin synthesis and GABA function, the gut dysbiosis reducing serotonin availability and increasing neuroinflammation, the HPA hyperreactivity amplifying every stress signal during the luteal window, and the blood sugar instability and thyroid dysfunction that worsen mood and neurological regulation independently of the hormonal cycle. For patients who also have chronic pain, we address the monthly central sensitization that PMDD produces as a direct component of the pain treatment plan. The goal is not just to make each luteal phase more survivable. It is to reduce the biological amplifiers sufficiently that the neurological sensitivity of PMDD stops governing two weeks out of every four.

PMDD AND THE REST OF THE BODY

PMDD does not stay in the emotional domain. It reaches into pain, energy, cognition, digestion, and every other physiological system — and every one of those domains benefits when the neurological sensitivity driving the condition is reduced.

At True Health Centers, we regularly see patients whose chronic pain, gut symptoms, and fatigue follow a clear premenstrual pattern that no one has ever named or treated as PMDD. When the hormonal and neurological picture is properly identified and addressed, the downstream improvements across all of these systems can be significant.

Premenstrual pain amplification

The central sensitization of PMDD reduces pain thresholds throughout the body during the luteal phase. Headaches, back pain, joint pain, and any existing musculoskeletal condition all become measurably worse in the premenstrual window. This is not coincidental variation — it is the direct neurological consequence of the same hormonal sensitivity that drives the mood symptoms. Addressing the PMDD picture reduces this monthly pain amplification cycle, often producing improvements in pain conditions that structural treatment alone had been unable to fully resolve.

Gut symptoms and the cycle

Bloating, diarrhea, constipation, and abdominal cramping often follow the same premenstrual timing as PMDD mood symptoms. The gut's enteric nervous system is directly influenced by the same hormonal and neurological changes of the luteal phase — prostaglandin production increases, gut motility shifts, and visceral sensitivity rises. Women with PMDD and concurrent IBS or gut sensitivity almost invariably find their gut symptoms at their worst in the same premenstrual window. Treating both the PMDD neurological sensitivity and the gut health picture simultaneously produces improvement in each that neither approach achieves alone.

PMDD and coexisting conditions

PMDD is significantly more common in women with a history of anxiety, depression, trauma, autoimmune conditions, thyroid disease, and PMOS. These are not independent associations — they reflect a shared neurobiological sensitivity pattern and an immune and hormonal environment that amplifies it. For any patient managing PMDD alongside another of these conditions, treating the conditions as separate entities with separate providers misses the integrative picture. Our clinic is built to see and address these connections simultaneously, because in practice they are almost never genuinely separate.

ALSO RELATED

PMDD often connects with:

TAKE THE NEXT STEP

The monthly cycle of PMDD is not inevitable. There are specific biological reasons it is as severe as it is — and they can be identified and addressed.